Serum osteopontin: a biomarker of disease activity and predictor of relapsing course in patients with giant cell arteritis. Potential clinical usefulness in tocilizumab-treated patients
Sergio Prieto-González, Nekane Terrades-García, Marc Corbera-Bellalta, Ester Planas-Rigol, Chie Miyabe, Marco A Alba, Ariel Ponce, Itziar Tavera-Bahillo, Giuseppe Murgia, Georgina Espígol-Frigolé, Javier Marco-Hernández, José Hernández-Rodríguez, Ana García-Martínez, Sebastian H Unizony, Maria C Cid
RMD Open Dec 2017, 3 (2) e000570; DOI: 10.1136/rmdopen-2017-000570